8,575 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Cathy Pareto & Associates Inc.

Cathy Pareto & Associates Inc. purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 8,575 shares of the company’s stock, valued at approximately $670,000.

Other large investors have also added to or reduced their stakes in the company. LGT Financial Advisors LLC boosted its holdings in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies during the third quarter worth about $31,000. Finally, Continuum Advisory LLC raised its position in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is currently owned by insiders.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $88.67 on Monday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The company has a market capitalization of $40.51 billion, a price-to-earnings ratio of 24.36, a price-to-earnings-growth ratio of 2.88 and a beta of 1.11. The company’s 50 day simple moving average is $82.32 and its 200-day simple moving average is $84.78. GE HealthCare Technologies Inc. has a 1 year low of $71.42 and a 1 year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.99 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.85%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. Evercore ISI increased their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.